.Novartis levels a new frontier in its own partnership along with Voyager Therapies, paying $15 thou...
.On the heels of an FDA denial for its chief competing Novo Nordisk, Eli Lilly is actually gaining g...
.Just a handful of months after dosing the initial individual in a stage 2 test for freshly identifi...
.Eli Lilly's search for weight problems targets has led it to the darker genome. The Big Pharma has ...
.Arsenal Biosciences is moving on up. The cell therapy provider has added on $325 million in ammo al...
.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...
.Aelis Farma's hopes of protecting an easy, favorable choice on a $one hundred thousand alternative ...
.ProKidney has stopped one of a set of stage 3 trials for its own tissue treatment for renal ailment...
.Vaxcyte unveiled what experts called "spectacular" period 1/2 data for its own 31-valent pneumococc...
.Recursion has actually stumbled via an early test of its own tech-enabled strategy to medicine reve...